India faces a growing liver disease crisis linked to obesity and diabetes, affecting even non-drinkers. Experts warn that ...

A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Scientists from Western University in Canada have discovered that a natural substance found in sweet oranges and tangerines could help fight obesity and protect against diseases like diabetes and ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

3 Overall, increased rates of complications were reported in several of the studies that included patients with obesity and/or diabetes. No increase in complications in patients who were smokers ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...